Four different antigenic sites (A-l, A-2, B-I, B-2) have been identified previously on the haemagglutininesterase (HE) glycoprotein of influenza C/Ann Arbor/I/50 virus with seven monoclonal antibodies (MAbs). In this study we produced 30 additional anti-HE MAbs, nine of which demonstrated at least one of the following activities: haemagglutination inhibition, receptor-destroying enzyme inhibition, haemolysis inhibition, and neutralization (group A). The remaining had none of these activities (group B). These antibodies, and those previously isolated, were used to construct a more complete antigenic map of the HE molecule.
The haemagglutinin-esterase (HE) glycoprotein of influenza C virus has three biological roles, receptor-binding, fusion with the host cell membrane and receptordestroying activity (Sugawara et al., 1985 Vlasak et al., 1987; Herrler et al., 1988a; Formanowski & Meier-Ewert, 1988) , the last of which has been identified as being carried out by a neuraminate-O-acetylesterase (Herder et al., 1985) . The glycoprotein may be present in virions as two proteolytic cleavage products, HE1 and HE2, that are held together by disulphide bonding (Herrler et al., 1979) . A stretch of hydrophobic amino acid residues at the N terminus of the smaller subunit (HE2) is thought to be responsible for membrane fusion (Herder et al., 1981 ; Pfeifer & Compans, 1984; Nakada et al., 1984) . Affinity labelling with [3H]diisopropylfluorophosphate (DFP) showed that amino acid 71 (serine) is the active site of neuraminate-O-acetylesterase (Herrler et al., 1988b; Vlasak et al., 1989) . DFP treatment of the virus inactivated the receptor-destroying activity without inhibiting the receptor-binding activity (Muchmore & Varki, 1987) , suggesting that these two functions may not share the same site on the HE protein. Very recently, influenza C virus mutants with changes in the receptorbinding properties were isolated in cell culture either by passaging the virus (Szepanski et al., 1992; Umetsu et al., 1992) or by allowing the virus to grow in the presence of anti-HE monoclonal antibodies (MAbs) . Sequence analyses of the HE genes of these mutants suggested that several amino acid residues in the central region of the HE1 subunit, spanning positions 178 to 284, may be involved in the binding to cellular receptors.
In our previous study, seven MAbs against the C/Ann Arbor/I/50 (C/AA/50) virus HE were isolated and classified into two groups. Group A MAbs (J9, J14, Q5, K16) demonstrated haemagglutination inhibition (HI), receptor-destroying enzyme inhibition (RDEI), and haemolysis inhibition (HLI) and neutralized virus infectivity, whereas group B MAbs (S16, J6, J15) showed none of these activities (Sugawara et al., 1988 ; Hachinohe et al., 1989) . Operational analysis with escape mutants selected with group A MAbs identified two nonoverlapping antigenic sites (A-l, A-2) on the HE molecule, and competitive binding assays with group B MAbs identified two additional non-overlapping antigenic sites (B-l, B-2). In this study we produced 30 additional anti-HE MAbs to aid identification of all antigenic sites on the glycoprotein and these, as well as the previously isolated ones, were used to construct a more complete antigenic map.
MAbs against the HE protein of C/AA/50 or C/Mississippi/I/80 (C/MS/80) virus were produced according to methods of Hongo et al. (1986) and Sugawara et al. (1991) . Their specificity was confirmed by radioimmunoprecipitation using lysates of [aSS]methionine-labelled HMV-II cells infected with C/AA/50 or C/MS/80 as antigens as described by Sugawara et al. (1991) 
* The data for isotype, biological activities, and reactivity with reduced HE for MAbs Q5, J9, J14, K16, S16, J15 and J6 were from and Hachinohe et al. (1989) . + H, high avidity, A4o ~ > 1.0; I, intermediate avidity, 0.5 < A405 ~< 1.0; L, low avidity, A405 ~< 0.5. :~ Western blotting was performed as described (Sugawara et al., 1988) , using ascitic fluids containing MAbs at dilutions of 1:200. +, Stained strongly; _, stained weakly; -, not stained. For MAbs reactive with reduced HE the subunit of the glycoprotein recognized is given in parentheses.
§ HI titres variable.
II MAbs obtained after immunization with C/MS/80. The others were prepared by immunizing with C/AA/50. ¶ <40. ** U.R., unreactive with either subunit.
anti-HE MAbs were first examined for reactivity with C/AA/50 virions in ELISA and HI, HLI and neutralization tests. These tests were carried out according to Sugawara et al. (1988) , and the RDEI test was performed with rat serum inhibitors as a substrate (Hachinohe et al., 1989) . The results, together with the data for the previously isolated anti-HE MAbs, are summarized in Table 1 . Of the 30 MAbs, 21 reacted to high titres in ELISA, but had no HI, RDEI, HLI and or neutralization activities, indicating that they belong to group B. The remaining nine MAbs were assigned to group A because they exhibited at least HI, RDEI or HLI activity, although five of them (U4, MS22, U5, U12, F18) demonstrated no detectable neutralization capacity. It should be noted that U5, U12 and F18, though they showed RDEI activity, did not show any detectable HI activity. The relative avid±ties of the antibodies were estimated by ELISA (Sugawara et al., 1991) , assuming that at antigen saturation the maximum amount of antibody bound to the wells is a direct reflection of the avidity of the antibody for its epitope (Frankel & Gerhard, 1979) . As seen in Table 1 , all the group A MAbs except F18 showed high avidity. The avid±ties of group B antibodies, in contrast, differed remarkably (1988) .
t MAb used for selection of antigenic variants. :~ Antigenic variant number. § Reactivity in ELISA/HI tests. +, ELISA and HI titres identical to those obtained with parental virus; +, ELISA titre 10-to 100-fold less than that with parental virus;-, titres at least 100-fold (ELISA) or 32-fold (HI) less than those with parental virus.
II NT, Not tested.
from one another: 10 MAbs (including S16, J6, J15) exhibited high avidity whereas the others had intermediate or low avidity. Previous analysis with antigenic variants selected with four group A MAbs identified two antigenic sites on the C/AA/50 HE, sites A-1 (recognized by J14, J9 and Q5) and A-2 (recognized by K16) (Sugawara et al., 1988) . To extend this observation, we isolated a number of antigenic variants with four newly prepared MAbs that had neutralization activity (U1, U2, U9, D37). These variants, together with those previously isolated, were tested for reactivity in ELISA and HI tests with each of 13 group A MAbs ( Table 2 ). The reactivity of D37 with antigenic variants was tested by ELISA alone because its HI activity, like that of K16 (Sugawara et al., 1988) , varied considerably from experiment to experiment. Antibody U9 showed reduced reactivity with the variants selected with Q5, and vice versa. The HI titres of U9 against the variants selected with J14 were also very low compared with the titre against the parent virus. This suggests that the epitope recognized by U9 is linked to those recognized by Q5 and J14, and is hence within site A-1. Although reciprocal analysis was prevented by the inability to use U4 to select variants, this ant±body's decreased reactivity against variants selected with U9, Q5 and J14 suggests that the epitope defined by U4 is also located in site A-1.
The variants selected with U1 and U2 displayed significantly decreased reactivity with U1, U2 and MS22 in both ELISA and HI tests but reacted to high titres with any of the other antibodies. The antigenic site recognized by U1 and U2 is therefore separate from the previously defined antigenic sites, A-1 and A-2, and was designated A-3. The failure of MS22 to react with the variants selected with U1 and U2 suggests that this MAb is also directed to site A-3. The variants selected with D37, though unreactive with the selecting antibody, reacted to high titres with any of the MAbs directed against sites A-1 to A-3. The antigenic site recognized by D37 was therefore designated A-4. The epitopes recognized by U5, U12 and F18 could not be assigned to A-1 to A-4 because these antibodies exhibited high titres in ELISAs against all of the variants described above (data not shown). Thus a minimum of five distinct antigenic sites [A-1 to A-4, and the site(s) recognized by U5, U12 and F18] were detected on the HE molecule by analysis with 13 group AMAbs.
To study the spatial relationship of the HE epitopes, competitive binding assays were performed, as described elsewhere (Sugawara et al., 1988) . Twelve group A and 10 group B MAbs of high avidity were used because assays with peroxidase-labelled intermediate or low avidity antibodies displayed unclear results (data not shown), as was observed previously with anti-nucleoprotein MAbs (Sugawara et al., 1991) . When analysis was carried out with MAbs against sites A-1 to A-4, high levels of competition were observed between two antibodies recognizing the same antigenic site. Little or no competition was detected with two antibodies to different antigenic sites (data not shown). The only exception was that K16 to site A-2 competed to a significant degree with J14 and J9 to site A-l, although the competition was non-reciprocal (Sugawara et al., 1988) . Antibodies U5 and U12 also competed with each other but not with any of the other group A MAbs tested (data not shown). The antigenic site recognized by these MAbs was therefore designated A-5.
The epitopes recognized by the three previously isolated group B MAbs have been divided, by competitive binding assays, into two non-overlapping sites, site B-1 (defined by S16) and site B-2 (defined by J6 and J15) (Sugawara et al., 1988) . Analysis with an increased number of group B MAbs identified two additional nonoverlapping antigenic sites, site B-3 recognized by U19 and site B-4 by Z2 (data not shown). At least nine nonoverlapping or partially overlapping antigenic sites (A-1 to A-5 and B-1 to B-4) are present, therefore, on the HE molecule of C/AA/50, as summarized in Table 1 .
Western blot analysis with the seven previously isolated MAbs revealed that heat denaturation of HE in the presence of SDS and 2-mercaptoethanol (2-ME) resultedin the loss of antigenic reactivity of sites A-1 and A-2, without influencing to any great degree the reactivity of sites B-1 and B-2 (Sugawara et al., 1988) . To extend this observation, unreduced and reduced forms of the HE protein were tested by Western blotting for their capacity to bind each of the 37 MAbs, after separating the proteins of MDCK cell-grown C/AA/50 virions by SDS-PAGE in the presence or absence of 2-ME. As shown in Table 1 , all group B MAbs reacted strongly with unreduced HE, indicating that the antigenic sites recognized by these antibodies were greatly resistant to heat denaturation in the presence of SDS alone. MAbs to sites A-3, A-4 and A-5 and the unassigned group A antibody (F 18) were also highly reactive with unreduced HE. In contrast, MAbs to sites A-1 and A-2 (except U4) were much less reactive with unreduced HE. Reduction of the HE protein by 2-ME caused complete loss of reactivity with all group A Mabs except, again, U4. These observations suggest that although the epitope recognized by U4 is linear, the integrity of all the other epitopes in sites A-1 to A-5 depends at least in part on the formation of disulphide bonds. Reduction of HE also affected its reactivity with some group B MAbs; this treatment caused a significant decrease in reactivity with site B-2 MAbs, though not with site B-l, B-3 and B-4 MAbs.
MAbs reactive with reduced HE were examined for reactivity with the HE1 and HE2 subunits of the glycoprotein, using as the antigen MDCK-grown C/AA/50 virions treated with trypsin (Table 1) . Antibody U4 against site A-1 bound to the HE1 subunit. All the MAbs against sites B-1, B-3 and B-4 also recognized the HE1 subunit. In contrast, antibodies against site B-2 bound to the HE2 subunit, except for J6 and H 1, which did not react with either subunit. Both the HEI and HE2 fragments might be involved in the formation of the epitopes recognized by J6 and H1.
Among the unassigned group B MAbs, two (MS4, MS5) bound to HE2 and three (U13, U7, F8) to neither subunit. These five antibodies were similar in this respect to those against site B-2.
Reactivity of anti-HE MAbs with uninfected HMV-II cells was examined by immunofluorescent staining according to the method described by Sugawara et al. (1991) . Four of 37 antibodies cross-reacted with cellular components. S 16 and U6 diffusely stained the cytoplasm of HMV-II cells, with intranuclear fuorescence associated predominantly with the nucleoli (Fig. 1 a, b) . The host cell antigen cross-reactive with U16 was detected in the nucleus as strong granular fluorescence (Fig. 1 c) and the antigen reactive with MS 12 appeared to be located in the nuclear membrane (Fig. 1 d) . Essentially identical staining patterns were seen when various cultures, including those of cells of human, monkey, canine and chicken origin, were stained with each of these antibodies.
Inhibition experiments with DFP suggested that the receptor-binding and -destroying activities of influenza C virus are not located at the same site on the HE molecule (Muchmore & Varki, 1987) and, indeed, we observed that receptor-destroying but not binding activity was inhibited by site A-5 MAbs. Amino acid 71 (serine) has been identified as the active site of viral acetylesterase (Herrler et al., 1988 b; Vlasak et al., 1989) and among the nine antigenic sites delineated on the HE protein, A-1 and A-3 may be located closest to the site responsible for attachment to cellular receptors. All MAbs against these, unlike those against the other antigenic sites, exhibited high titres of HI activity. Recently it was also discovered that most of the escape mutants selected with these MAbs had altered haemagglutination properties . Analysis of the mutants' HE sequences revealed that amino acid changes at residues 178, 186, 187, 190, 206 and 212 decreased the haemagglutinating activity whereas those at residues 245 and 283 produced the opposite effect , suggesting that these amino acids are located at or close to the receptor-binding site. No significant differences were detected in the receptor-destroying capacity of escape mutants with altered receptor-binding activity compared with that of parent virus (data not shown), again suggesting that the two functions are located at separate sites.
MAbs specific for the smaller haemagglutinin (HA) subunit (HA2) of influenza A virus have been prepared by immunizing animals with the isolated HA2 (Becht et al., 1984) . To our knowledge, however, anti-HA2 MAbs have not yet been isolated from mice immunized with either intact virions or purified HA proteins, so the HA2 subunit is at best only very weakly immunogenic, unless isolated.
In this study, seven MAbs, five of which were directed against site B-2, recognized the HE2 subunit. Hybridomas specific for site B-2 were isolated more frequently than those for any of the other antigenic sites (Table 1) . The smaller subunit of influenza C virus HE, unlike that of influenza A virus HA, may be highly immunogenic. Four anti-HE M A b s (S16, U6, MS12, U16) crossreacted with host cell antigens. This was not due to the recognition of carbohydrate epitopes because all the group B MAbs, including four antibodies described above, reacted strongly with carbohydrate-free H E protein synthesized in the presence o f tunicamycin (data not shown). The epitopes recognized by S16, MS12 and U16 are presumably composed o f linear amino acid sequences since they reacted strongly with the H E protein heat-denatured in the presence o f SDS and 2-ME. U6 was also reactive, though weakly, with a denatured H E protein, so this antibody m a y also recognize a linear epitope. The most likely explanation for the observed cross-reactions is that there are host cell proteins which contain amino acid sequences very similar to the viral antigenic determinants described above. The significance of cross-reacting antibodies in pathogenesis and the nature of the cross-reacting host cell proteins remain to be elucidated.
